Lehrstuhl für Innere Medizin V

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Elevated high-density lipoprotein levels following acute graft-versus-host disease onset: a potential link to T-cell dysfunction and increased relapse risk (2025) Böttcher-Loschinski R, Karl F, Drettwan D, Wittmann J, Jacobs B, Völkl S, Bruns H, et al. Journal article Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus (2025) Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber Bouyer R, Hagen M, et al. Journal article Effects of different B-cell-depleting strategies on the lymphatic tissue (2025) Tur C, Eckstein M, Bucci L, Auth J, Bergmann C, Rauber S, Hagen M, et al. Journal article Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma (2025) Müller F, Schwingen NR, Hagen M, Scholz JK, Aigner M, Wirsching A, Taubmann J, et al. Journal article CAR-T-Zellen bei nicht-malignen Erkrankungen (2025) Müller F, Hagen M, Schett G, Mackensen A Journal article Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT (2025) Flamann C, Shaikh H, Matos C, Kreutz M, Ali H, Kern MA, Büttner-Herold M, et al. Journal article Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD (2025) Habenicht K, Wanzek J, Bootz A, Schäfer S, Vollmer L, Hiergeist A, Fante M, et al. Journal article Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study (2025) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Düsing C, Krickau T, et al. Journal article Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group (2025) Katsivelos N, Spyrou N, Weber D, Vasova I, Ayuk F, Choe H, Hogan W, et al. Journal article